Sumagang, Jerick .
HRN: 22-44-03 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/10/2025
CEFIXIME 100MG/5ML, 60ML SUSPENSION (BOT)
02/10/2025
02/15/2025
ORAL
3ml
Q12
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes